Form 4 for DMRA Damora Therapeutics, Inc.

Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-004568 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-06	2026-01-02	DMRA	Winslow Garrett	GC	S - Sale+OE	$21.38	-255	1,854	-12%	-$5,452
D	2026-01-06	2026-01-02	DMRA	Winslow Garrett	GC	M - OptEx	—	+680	2,109	+48%	—
D	2026-01-06	2026-01-02	DMRA	Winslow Garrett	GC	M - OptEx	$0.00	-680	1,320	-34%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-02	S	D	255	$21.38	1,854	D	—	—
2	Common	Common Stock	2026-01-02	M	A	680	—	2,109	D	—	—	(F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
3	Derivative	Restricted Stock Units	2026-01-02	M	D	680	$0.00	1,320	D	— · — to —	680 Common Stock	(F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. (F3) This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.